Diffusion-weighted imaging in head and neck cancers

Future Oncology

Volumn 5, Issue 7, 2009, Pages 959-975

  Chawla, Sanjeev ^a   Kim, Sungheon ^a,b   Wang, Sumei ^a   Poptani, Harish ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apparent diffusion coefficient; Diffusion weighted imaging; Head and neck cancers; Lymphadenopathy; Salivary gland tumors; Squamous cell carcinomas of head and neck

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18; GADOLINIUM PENTETATE; IRON OXIDE;

CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; HEAD AND NECK CANCER; HEAD AND NECK SURGERY; HUMAN; IMAGE QUALITY; LYMPH NODE METASTASIS; MINIMAL RESIDUAL DISEASE; MONITORING; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SALIVARY GLAND TUMOR; TREATMENT RESPONSE; TUMOR NECROSIS; ANIMAL; HEAD AND NECK TUMOR;

ANIMALS; DIFFUSION MAGNETIC RESONANCE IMAGING; HEAD AND NECK NEOPLASMS; HUMANS;

EID: 73349133362     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.09.77     Document Type: Review

References (115)

1. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J. Clin. 55, 74-108 (2005).
2. Pande P, Soni S, Kaur J et al.: Prognostic factors in betel and tobacco related oral cancer. Oral Oncol. 38, 491-499 (2002).
3. Argiris A, Haraf DJ, Kies MS, Vokes EE: Intensive concurrent chemoradiotherapy for head and neck cancer with 5-fluorouracil- and hydroxyurea-based regimens: reversing a pattern of failure. Oncologist 8, 350-360 (2003).
4. Funk GF, Karnell LH, Robinson RA et al.: Presentation, treatment, and outcome of oral cavity cancer: a national cancer data base report. Head Neck 24, 165-180 (2002).
5. Syrjanen S: Human papillomavirus infections and oral tumors. Med. Microbiol. Immunol. 192, 123-128 (2003).
6. Scully C, Field JK, Tanzawa H: Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control. Oral Oncol. 36, 256-263 (2000).
7. McGurk M, Chan C, Jones J, O'Regan E, Sherriff M: Delay in diagnosis and its effect on outcome in head and neck cancer. Br. J. Oral Maxillofac. Surg. 43, 281-284 (2005).
8. Schechter NR, Gillenwater AM, Byers RM et al.: Can positron emission tomography improve the quality of care for head-and-neck cancer patients? Int. J. Radiat. Oncol. Biol. Phys. 51, 4-9 (2001).
9. Schwartz DL, Rajendran J, Yueh B et al.: Staging of head and neck squamous cell cancer with extended-field FDG-PET. Arch. Otolaryngol. Head Neck Surg. 129, 1173-1178 (2003).
10. 18F-FDG-PET/ CT for staging of oral squamous cell carcinoma. Head Neck 30, 1488-1496 (2008).
11. Yao M, Smith RB, Graham MM et al.: The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment. Int. J. Radiat. Oncol. Biol. Phys. 63, 991-999 (2005).
12. 18F-fluorodeoxyglucose to predict pathologic response after induction chemotherapy and definitive chemoradiotherapy in head and neck cancer. Head Neck 26, 890-896 (2004).
13. Imaizumi A, Yoshino N, Yamada I et al.: A potential pitfall of MR imaging for assessing mandibular invasion of squamous cell carcinoma in the oral cavity. AJNR Am. J. Neuroradiol. 27, 114-122 (2006).
14. Ahmad A, Branstetter BFT: CT versus MR: still a tough decision. Otolaryngol. Clin. North Am. 41, 1-22 (2008).
15. Tartaglino LM, Rao VM, Markiewicz DA: Imaging of radiation changes in the head and neck. Semin. Roentgenol. 29, 81-91 (1994).
16. Mukherji SK, Schiro S, Castillo M, Kwock L, Muller KE, Blackstock W: Proton MR spectroscopy of squamous cell carcinoma of the extracranial head and neck: in vitro and in vivo studies. AJNR Am. J. Neuroradiol. 18, 1057-1072 (1997).
17. StarLack JM, Adalsteinsson E, Adam MF et al.: In vivo 1h MR spectroscopy of human head and neck lymph node metastasis and comparison with oxygen tension measurements. AJNR Am. J. Neuroradiol. 21, 183-193 (2000).
18. Maldonado X, Alonso J, Giralt J et al.: 31 phosphorus magnetic resonance spectroscopy in the assessment of head and neck tumors. Int. J. Radiat. Oncol. Biol. Phys. 40, 309-312 (1998).
19. ShuklaDave A, Poptani H, Loevner LA et al.: Prediction of treatment response of head and neck cancers with P-31 MR spectroscopy from pretreatment relative phosphomonoester levels. Acad. Radiol. 9, 688-694 (2002).
20. Hoskin PJ, Saunders MI, Goodchild K et al.: Dynamic contrast enhanced magnetic resonance scanning as a predictor of response to accelerated radiotherapy for advanced head and neck cancer. Br. J. Radiol. 72, 1093-1098 (1999).
21. Wang J, Takashima S, Takayama F et al.: Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging. Radiology 220, 621-630 (2001).
22. Sumi M, Sakihama N, Sumi T et al.: Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer. AJNR Am. J. Neuroradiol. 24, 1627-1634 (2003).
23. Srinivasan A, Dvorak R, Perni K, Rohrer S, Mukherji SK: Differentiation of benign and malignant pathology in the head and neck using 3T apparent diffusion coefficient values: early experience. AJNR Am. J. Neuroradiol. 29, 40-44 (2008). ■ Demonstrates that diffusion-weighted images (DWI) and apparent diffusion coefficient (ADC) maps can be obtained using clinically higher magnetic field (3T) magnets with optimal quality and that ADC values of benign and malignant neck pathologies are significantly different from each other.
24. Vandecaveye V, De Keyzer F, Nuyts S et al.: Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings. Int. J. Radiat. Oncol. Biol. Phys. 67, 960-971 (2007). ■■ Outlines the importance of DWI in differentiating persistent or recurrent squamous cell carcinoma of the head and neck from nontumoral tissue changes after chemoradiotherapy. These findings may have a significant impact on patient management.
25. Vandecaveye V, De Keyzer F, Vander Poorten V et al.: Head and neck squamous cell carcinoma: value of diffusion-weighted mr imaging for nodal staging. Radiology 251, 134-146 (2009). ■■ Reports that ADC values are more accurate than conventional turbo spin echo MRI for nodal staging. In addition, the manuscript suggests that ADC maps provide added value in the detection of subcentimeter nodal metastases, which are generally not observed by conventional cross-sectional imaging methods including CT scanning, MRI and PET.
26. Abdel Razek AA, Kandeel AY, Soliman N et al.: Role of diffusion-weighted echo-planar MR imaging in differentiation of residual or recurrent head and neck tumors and posttreatment changes. AJNR Am. J. Neuroradiol. 28, 1146-1152 (2007). ■ ADC values were demonstrated to differentiate residual or recurrent head and neck tumors from postoperative or postradiation changes.
27. Razek AA, Megahed AS, Denewer A et al.: Role of diffusion-weighted magnetic resonance imaging in differentiation between the viable and necrotic parts of head and neck tumors. Acta Radiol. 49, 364-370 (2008). ■ Concludes that ADC is helpful in differentiation between viable and necrotic parts of head and neck tumors. These findings may assist better targeting of biopsy sites for accurate histopathological diagnosis.
28. Maeda M, Kato H, Sakuma H, Maier SE, Takeda K: Usefulness of the apparent diffusion coefficient in line scan diffusion-weighted imaging for distinguishing between squamous cell carcinomas and malignant lymphomas of the head and neck. AJNR Am. J. Neuroradiol. 26, 1186-1192 (2005).
29. Kim S, Loevner L, Quon H et al.: Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin. Cancer Res. 15, 986-994 (2009). ■■ The prognostic value of pretreatment ADC values in the prediction of early treatment response to chemoradiation therapy of patients with squamous cell carcinoma of the head and neck is reported. Early assessment of treatment response may assist in better selection of alternative treatment strategies.
30. Padhani AR, Liu G, MuKoh D et al.: Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 11, 102-125 (2009). ■■ Discusses the current understanding of pathophysiologic basis of DWI as a potential cancer biomarker. It also provides recommendations for measurement, image display and ana lysis methods for clinical DWI data.
31. Tsuruda JS, Chew WM, Moseley ME, Norman D: Diffusion-weighted MR imaging of the brain: value of differentiating between extraaxial cysts and epidermoid tumors. AJR Am. J. Roentgenol. 155, 1059-1065 (1990).
32. Okamoto K, Ito J, Ishikawa K, Sakai K, Tokiguchi S: Diffusion-weighted echoplanar MR imaging in differential diagnosis of brain tumors and tumor-like conditions. Eur. Radiol. 10, 1342-1350 (2000).
33. Bammer R, Fazekas F: Diffusion imaging of the human spinal cord and the vertebral column. Top Magn. Reson. Imaging 14, 461-476 (2003).
34. Vandecaveye V, De Keyzer F, Dymarkowski S: Perfusion-and diffusion-weighted imaging of hepatocellular carcinoma. JBR-BTR 90, 492-496 (2007).
35. Kim S, Naik M, Sigmund E, Taouli B: Diffusion-weighted MR imaging of the kidneys and the urinary tract. Magn. Reson. Imaging Clin. N. Am. 16, 585-596 (2008).
36. Stejskal EO, Tanner J: Spin diffusion measurements: spin echoes in the presence of a time-dependent field gradient. J. Chem. Phys. 42, 288-292 (1965).
37. Colagrande S, Belli G, Politi LS, Mannelli L, Pasquinelli F, Villari N: The influence of diffusion-and relaxation-related factors on signal intensity: an introductive guide to magnetic resonance diffusion-weighted imaging studies. J. Comput. Assist. Tomogr. 32, 463-474 (2008).
38. Gray L, MacFall J: Overview of diffusion imaging. Magn. Reson. Imaging Clin. N. Am. 6, 125-138 (1998).
39. Thoeny HC, De Keyzer F: Extracranial applications of diffusion-weighted magnetic resonance imaging. Eur. Radiol. 17, 1385-1393 (2007).
40. Le Bihan D, Breton E, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M: MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 161, 401-407 (1986).
41. Turner R, Le Bihan D, Maier J, Vavrek R, Hedges LK, Pekar J: Echo-planar imaging of intravoxel incoherent motion. Radiology 177, 407-414 (1990).
42. Deng J, Miller FH, Salem R, Omary RA, Larson AC: Multishot diffusion-weighted propeller magnetic resonance imaging of the abdomen. Invest. Radiol. 41, 769-775 (2006).
43. Friedrich KM, Matzek W, Gentzsch S, Sulzbacher I, Czerny C, Herneth AM: Diffusionweighted magnetic resonance imaging of head and neck squamous cell carcinomas. Eur. J. Radiol. 68, 493-498 (2008).
44. Srinivasan A, Dvorak R, Rohrer S, Mukherji SK: Initial experience of 3-tesla apparent diffusion coefficient values in characterizing squamous cell carcinomas of the head and neck. Acta Radiol. 49, 1079-1084 (2008).
45. Gupta RK, Cloughesy TF, Sinha U et al.: Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma. J. Neurooncol. 50, 215-226 (2000).
46. Guo AC, Cummings TJ, Dash RC, Provenzale JM: Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology 224, 177-183 (2002).
47. Lyng H, Haraldseth O, Rofstad EK: Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging. Magn. Reson. Med. 43, 828-836 (2000).
48. Alvarez-Linera J, Benito-Leon J, Escribano J, Rey G: Predicting the histopathological grade of cerebral gliomas using high b value MR DW imaging at 3-tesla. J. Neuroimaging 18, 276-281 (2008).
49. Akter M, Hirai T, Makino K et al.: Diffusion-weighted imaging of primary brain lymphomas: effect of ADC value and signal intensity of T2-weighted imaging. Comput. Med. Imaging Graph 32, 539-543 (2008).
50. Mishra AM, Gupta RK, Saksena S et al.: Biological correlates of diffusivity in brain abscess. Magn. Reson. Med. 54, 878-885 (2005).
51. Kotsenas AL, Roth TC, Manness WK, Faerber EN: Abnormal diffusion-weighted MRI in medulloblastoma: does it reflect small cell histology? Pediatr. Radiol. 29, 524-526 (1999).
52. Jakobsen J, Hansen O, Jorgensen KE, Bastholt L: Lymph node metastases from laryngeal and pharyngeal carcinomas - calculation of burden of metastasis and its impact on prognosis. Acta Oncol. 37, 489-493 (1998).
53. de Bondt RB, Nelemans PJ, Hofman PA et al.: Detection of lymph node metastases in head and neck cancer: a meta-ana lysis comparing US, US guided FNAC, CT and MR imaging. Eur. J. Radiol. 64, 266-272 (2007).
54. Sigal R, Vogl T, Casselman J et al.: Lymph node metastases from head and neck squamous cell carcinoma: MR imaging with ultrasmall superparamagnetic iron oxide particles (Sinerem MR) - results of a Phase-III multicenter clinical trial. Eur. Radiol. 12, 1104-1113 (2002).
55. Mack MG, Balzer JO, Straub R, Eichler K, Vogl TJ: Superparamagnetic iron oxide-enhanced MR imaging of head and neck lymph nodes. Radiology 222, 239-244 (2002).
56. White ML, Zhang Y, Robinson RA: Evaluating tumors and tumor like lesions of the nasal cavity, the paranasal sinuses, and the adjacent skull base with diffusion-weighted MRI. J. Comput. Assist. Tomogr. 30, 490-495 (2006).
57. Chong VF, Fan YF, Khoo JB: MRI features of cervical nodal necrosis in metastatic disease. Clin. Radiol. 51, 103-109 (1996).
58. Abdel Razek AA, Soliman NY, Elkhamary S, Alsharaway MK, Tawfik A: Role of diffusion-weighted MR imaging in cervical lymphadenopathy. Eur. Radiol. 16, 1468-1477 (2006).
59. Koc O, Paksoy Y, Erayman I, Kivrak AS, Arbag H: Role of diffusion weighted MR in the discrimination diagnosis of the cystic and/or necrotic head and neck lesions. Eur. J. Radiol. 62, 205-213 (2007).
60. Saboorian MH, Ashfaq R: The use of fine needle aspiration biopsy in the evaluation of lymphadenopathy. Semin. Diagn. Pathol. 18, 110-123 (2001).
61. Tandon S, Shahab R, Benton JI, Ghosh SK, Sheard J, Jones TM: Fine-needle aspiration cytology in a regional head and neck cancer center: comparison with a systematic review and meta-ana lysis. Head Neck 30, 1246-1252 (2008).
62. Grunert P, Espinosa J, Busert C et al.: Stereotactic biopsies guided by an optical navigation system: technique and clinical experience. Minim. Invasive Neurosurg. 45, 11-15 (2002).
63. Gupta S, Madoff DC: Image-guided percutaneous needle biopsy in cancer diagnosis and staging. Tech. Vasc. Interv. Radiol. 10, 88-101 (2007).
64. Ang KK, Harris J, Garden AS et al.: Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: radiation therapy oncology group Phase II trial 99-14. J. Clin. Oncol. 23, 3008-3015 (2005).
65. Lorch JH, Posner MR, Wirth LJ, Haddad RI: Induction chemotherapy in locally advanced head and neck cancer: a new standard of care? Hematol. Oncol. Clin. North Am. 22, 1155-1163 (2008).
66. Mehra R, Cohen RB, Burtness BA: The role of cetuximab for the treatment of squamous cell carcinoma of the head and neck. Clin. Adv. Hematol. Oncol. 6, 742-750 (2008).
67. Fajardo LF: Basic mechanisms and general morphology of radiation injury. Semin. Roentgenol. 28, 297-302 (1993).
68. Lapela M, Grenman R, Kurki T et al.: Head and neck cancer: detection of recurrence with PET and 2-[F-18] fluoro-2-deoxy-D-glucose. Radiology 197, 205-211 (1995).
69. 18FDG-PET for the assessment of primary head and neck tumors: clinical, computed tomography, and histopathological correlation in 38 patients. Laryngoscope 108, 1578-1583 (1998).
70. McGuirt WF, Greven KM, Keyes JW Jr et al.: Positron emission tomography in the evaluation of laryngeal carcinoma. Ann. Otol. Rhinol. Laryngol. 104, 274-278 (1995).
71. Myers EN, Fagan JJ: Treatment of the N+ neck in squamous cell carcinoma of the upper aerodigestive tract. Otolaryngol. Clin. North Am. 31, 671-686 (1998).
72. Terhaard CH, Bongers V, van Rijk PP, Hordijk GJ: F-18-fluoro-deoxy- glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/pharyngeal cancer. Head Neck 23, 933-941 (2001).
73. Hein PA, Eskey CJ, Dunn JF, Hug EB: Diffusion-weighted imaging in the follow-up of treated high-grade gliomas: tumor recurrence versus radiation injury. AJNR Am. J. Neuroradiol. 25, 201-209 (2004).
74. Baur A, Huber A, Arbogast S et al.: Diffusion-weighted imaging of tumor recurrencies and posttherapeutical soft-tissue changes in humans. Eur. Radiol. 11, 828-833 (2001).
75. Philippens ME, Gambarota G, van der Kogel AJ, Heerschap A: Radiation effects in the rat spinal cord: evaluation with apparent diffusion coefficient versus T2 at serial MR imaging. Radiology 250, 387-397 (2009).
76. Hackney DB: Forget the diffusion - do we need T2-weighted MR images to detect early central nervous system injury? Radiology 250, 303-304 (2009).
77. Zorat PL, Paccagnella A, Cavaniglia G et al.: Randomized Phase III trial of neoadjuvant chemotherapy in head and neck cancer: 10-year follow-up. J. Natl Cancer Inst. 96, 1714-1717 (2004).
78. Bonner JA, Harari PM, Giralt J et al.: Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 354, 567-578 (2006).
79. Chenevert TL, McKeever PE, Ross BD: Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin. Cancer Res. 3, 1457-1466 (1997).
80. Poptani H, Puumalainen AM, Grohn OH et al.: Monitoring thymidine kinase and ganciclovirinduced changes in rat malignant glioma in vivo by nuclear magnetic resonance imaging. Cancer Gene Ther. 5, 101-109 (1998).
81. Lemaire L, Howe FA, Rodrigues LM, Griffiths JR: Assessment of induced rat mammary tumour response to chemotherapy using the apparent diffusion coefficient of tissue water as determined by diffusion-weighted 1H-NMR spectroscopy in vivo. MAGMA 8, 20-26 (1999).
82. Mardor Y, Roth Y, Ochershvilli A et al.: Pretreatment prediction of brain tumors' response to radiation therapy using high b-value diffusion-weighted MRI. Neoplasia 6, 136-142 (2004).
83. Dzik-Jurasz A, Domenig C, George M et al.: Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet 360, 307-308 (2002).
84. McVeigh PZ, Syed AM, Milosevic M, Fyles A, Haider MA: Diffusion-weighted MRI in cervical cancer. Eur. Radiol. 18, 1058-1064 (2008).
85. Hermans R, Meijerink M, van den Bogaert W et al.: Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 57, 1351-1356 (2003).
86. Schmitt P, Kotas M, Tobermann A, Haase A, Flentje M: Quantitative tissue perfusion measurements in head and neck carcinoma patients before and during radiation therapy with a non-invasive MR imaging spin-labeling technique. Radiother. Oncol. 67, 27-34 (2003).
87. Robinson SP, Collingridge DR, Howe FA et al.: Tumour response to hypercapnia and hyperoxia monitored by flood magnetic resonance imaging. NMR Biomed. 12, 98-106 (1999).
88. Gandhi D, Chepeha DB, Miller T et al.: Correlation between initial and early follow-up CT perfusion parameters with endoscopic tumor response in patients with advanced squamous cell carcinomas of the oropharynx treated with organ-preservation therapy. AJNR Am. J. Neuroradiol. 27, 101-106 (2006).
89. Cao Y, Popovtzer A, Li D et al.: Early prediction of outcome in advanced head-and-neck cancer based on tumor blood volume alterations during therapy: a prospective study. Int. J. Radiat. Oncol. Biol. Phys. 72, 1287-1290 (2008).
90. Zima A, Carlos R, Gandhi D et al.: Can pretreatment CT perfusion predict response of advanced squamous cell carcinoma of the upper aerodigestive tract treated with induction chemotherapy? AJNR Am. J. Neuroradiol. 28, 328-334 (2007).
91. Kauppinen RA: Monitoring cytotoxic tumour treatment response by diffusion magnetic resonance imaging and proton spectroscopy. NMR Biomed. 15, 6-17 (2002).
92. Heller KS, Attie JN: Treatment of warthin's tumor by enucleation. Am. J. Surg. 156, 294-296 (1988).
93. Witt RL: The significance of the margin in parotid surgery for pleomorphic adenoma. Laryngoscope 112, 2141-2154 (2002).
94. Al-Khafaji BM, Nestok BR, Katz RL: Fine-needle aspiration of 154 parotid masses with histologic correlation: ten-year experience at the University of Texas M. D. Anderson Cancer Center. Cancer 84, 153-159 (1998).
95. Zbaren P, Nuyens M, Loosli H, Stauffer E: Diagnostic accuracy of fine-needle aspiration cytology and frozen section in primary parotid carcinoma. Cancer 100, 1876-1883 (2004).
96. Mukunyadzi P, Bardales RH, Palmer HE, Stanley MW: Tissue effects of salivary gland fine-needle aspiration. Does this procedure preclude accurate histologic diagnosis? Am. J. Clin. Pathol. 114, 741-745 (2000).
97. Mighell AJ, High AS: Histological identification of carcinoma in 21 gauge needle tracks after fine needle aspiration biopsy of head and neck carcinoma. J. Clin. Pathol. 51, 241-243 (1998).
98. Freling NJ, Molenaar WM, Vermey A et al.: Malignant parotid tumors: clinical use of MR imaging and histologic correlation. Radiology 185, 691-696 (1992).
99. Joe VQ, Westesson PL: Tumors of the parotid gland: MR imaging characteristics of various histologic types. AJR Am. J. Roentgenol. 163, 433-438 (1994).
100. Habermann CR, Gossrau P, Graessner J et al.: Diffusion-weighted echo-planar MRI: a valuable tool for differentiating primary parotid gland tumors? Rofo 177, 940-945 (2005).
101. Eida S, Sumi M, Sakihama N, Takahashi H, Nakamura T: Apparent diffusion coefficient mapping of salivary gland tumors: prediction of the benignancy and malignancy. AJNR Am. J. Neuroradiol. 28, 116-121 (2007).
102. Yabuuchi H, Matsuo Y, Kamitani T et al.: Parotid gland tumors: can addition of diffusion-weighted MR imaging to dynamic contrast-enhanced MR imaging improve diagnostic accuracy in characterization? Radiology 249, 909-916 (2008).
103. Habermann CR, Arndt C, Graessner J et al.: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? AJNR Am. J. Neuroradiol. 30, 591-596 (2009).
104. Matsushima N, Maeda M, Takamura M, Takeda K: Apparent diffusion coefficients of benign and malignant salivary gland tumors. Comparison to histopathological findings. J. Neuroradiol. 34, 183-189 (2007).
105. Vogl TJ, Dresel SH, Spath M et al.: Parotid gland: plain and gadolinium-enhanced MR imaging. Radiology 177, 667-674 (1990).
106. Huisman TA, Loenneker T, Barta G et al.: Quantitative diffusion tensor MR imaging of the brain: field strength related variance of apparent diffusion coefficient (ADC) and fractional anisotropy (FA) scalars. Eur. Radiol. 16, 1651-1658 (2006).
107. Grieve SM, Blamire AM, Styles P: Elimination of nyquist ghosting caused by read-out to phase-encode gradient cross-terms in EPI. Magn. Reson. Med. 47, 337-343 (2002).
108. Schmitz BL, Aschoff AJ, Hoffmann MH, Gron G: Advantages and pitfalls in 3T MR brain imaging: a pictorial review. AJNR Am. J. Neuroradiol. 26, 2229-2237 (2005).
109. Bammer R, Schoenberg SO: Current concepts and advances in clinical parallel magnetic resonance imaging. Top Magn. Reson. Imaging 15, 129-158 (2004).
110. Yoshino N, Yamada I, Ohbayashi N et al.: Salivary glands and lesions: evaluation of apparent diffusion coefficients with splitecho diffusion-weighted MR imaging - initial results. Radiology 221, 837-842 (2001).
111. Kito S, Morimoto Y, Tanaka T et al.: Utility of diffusion-weighted images using fast asymmetric spin-echo sequences for detection of abscess formation in the head and neck region. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 101, 231-238 (2006).
112. Sakamoto J, Yoshino N, Okochi K et al.: Tissue characterization of head and neck lesions using diffusion-weighted MR imaging with SPLICE. Eur. J. Radiol. 69, 260-268 (2009).
113. Wintersperger BJ, Runge VM, Biswas J et al.: Brain magnetic resonance imaging at 3 tesla using BLADE compared with standard rectilinear data sampling. Invest. Radiol. 41, 586-592 (2006).
114. Pipe JG: Motion correction with PROPELLER MRI: application to head motion and free-breathing cardiac imaging. Magn. Reson. Med. 42, 963-969 (1999).
115. Fries P, Runge VM, Kirchin MA et al.: Diffusion-weighted imaging in patients with acute brain ischemia at 3 T: current possibilities and future perspectives comparing conventional echoplanar diffusion-weighted imaging and fast spin echo diffusion-weighted imaging sequences using BLADE (PROPELLER). Invest. Radiol. 44, 351-359 (2009).